Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.
VNDA
Valuace
70
Růst
0
Zdraví
59
Cena
$ 4.44
Dnes
+0.02 (0.27%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-2
PS
2
Cena 1R
4-10
⌀ Cena
5.00
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-02-2026
Poslední dividenda

Profil

Společnost Vanda Pharmaceuticals Inc., biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci terapií pro řešení vysokých nenaplněných zdravotních potřeb. Mezi produkty společnosti uváděné na trh patří HETLIOZ pro léčbu poruch spánku trvajících 24 hodin a Fanapt perorální tablety pro léčbu schizofrenie. Mezi vyvíjené produkty patří HETLIOZ (tasimelteon) pro léčbu poruch páteřní lag, smith-magenisův syndrom, pediatrický Non-24, autistické spektrum a poruchy spánkové fáze; Fanapt (iloperidon) pro léčbu bipolární poruchy a dlouhodobě působící injekční formulační program pro léčbu schizofrenie; a Tradipitant (VLY-686), antagonista receptoru pro malý molekulární neurokinin-1 (NK-1R), pro léčbu atopické dermatitidy, gastronomy ropézie a kinetóza. Mezi vyvíjené produkty společnosti patří také VTR-297, inhibitor malé molekuly histondeacetylázy pro léčbu hematologických malignit a s potenciálním využitím jako léčba různých onkologických indikací; VQW-765, malý molekulární nikotinový acetylcholinový receptor parciální agonista pro léčbu psychiatrických poruch; portfolio cystických fibróz transmembránových regulátorů vodivosti a inhibitorů pro léčbu suchého očního a očního zánětu, stejně jako BPO-27 pro léčbu sekrece průjmové poruchy, včetně cholery; a VHX- 896, účinný metabolit iloperidonu. Své produkty prodává ve Spojených státech, Evropě a Izraeli. Společnost Vanda Pharmaceuticals Inc. byla založena v roce 2002 a sídlí ve Washingtonu v District of Columbia.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
368
Založení
2006-04-12
Adresa
2200 Pennsylvania Avenue NW
CEO
Mihael H. Polymeropoulos

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues216.1216.1198.8192.6254.4268.7248.2227.2193.1165.1146.0109.950.233.932.731.335.2
Cost of Revenues14.813.011.314.824.325.623.424.520.517.824.723.51.60.00.10.04.4
Gross Profit201.3203.1187.5177.8230.1243.1224.8202.7172.6147.2121.386.548.633.932.631.330.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues57.256.352.650.053.247.750.547.545.338.8
Cost of Revenues3.83.04.53.52.62.64.55.53.53.1
Gross Profit53.453.348.146.550.645.146.042.041.835.8
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.076.885.875.455.648.643.638.529.229.119.228.245.429.012.3
Selling General & Admin Expenses0.00.00.0112.9136.5124.0140.5129.7105.8123.899.884.584.624.613.911.510.1
Depreciation & Amortization10.911.98.13.01.51.52.91.51.51.810.913.02.31.51.51.51.8
Total Operating Expenses356.0354.2228.1191.8223.8200.9197.6179.9150.9164.1139.9126.6106.154.360.842.022.5
Operating Income-154.7-151.2-40.7-14.06.342.227.222.821.7-16.9-18.6-40.220.1-20.4-28.2-10.78.3
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.024.316.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.023.624.8
Depreciation & Amortization5.92.12.01.02.02.02.02.21.20.6
Total Operating Expenses93.784.686.691.160.956.156.151.248.941.7
Operating Income-40.4-31.3-38.5-44.5-10.3-11.0-10.1-9.2-7.1-6.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.50.4
Interest Expense0.00.00.00.0-5.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Expense16.012.517.720.35.00.24.46.23.61.50.70.377.70.10.60.50.5
IBT-138.6-138.6-22.96.311.342.431.729.025.3-15.4-17.9-39.920.2-20.3-27.7-10.29.3
Income Tax Expense81.881.8-4.03.85.09.28.3-86.50.10.10.10.0-77.60.00.0-0.42.1
Net Income-220.5-220.5-18.92.56.333.223.3115.625.2-15.6-18.0-39.920.2-20.3-27.7-9.87.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.05.9
Interest Expense0.00.00.00.00.00.00.00.00.00.0
Other Expense2.42.93.67.23.84.84.64.65.45.9
IBT-38.0-28.4-34.9-37.4-6.5-6.2-5.5-4.7-1.7-0.1
Income Tax Expense103.2-5.8-7.7-7.9-1.6-0.9-1.0-0.50.7-0.3
Net Income-141.2-22.6-27.2-29.5-4.9-5.3-4.5-4.1-2.40.1
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$0.04$0.11$0.60$0.43$2.17$0.50$-0.35$-0.41$-0.94$0.58$-0.67$-0.98$-0.35$0.26
EPS Diluted$0.00$0.00$0.00$0.04$0.11$0.58$0.42$2.11$0.48$-0.35$-0.41$-0.94$0.55$-0.67$-0.98$-0.35$0.25
Shares Outstanding59.158.958.157.456.555.554.453.150.944.743.442.334.830.428.228.127.9
Diluted Shares Outstanding59.158.958.157.657.056.955.254.853.044.743.442.336.730.428.228.128.5
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.04$0.00
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.04$0.00
Shares Outstanding59.158.959.058.558.358.358.257.857.557.5
Diluted Shares Outstanding59.158.959.058.558.358.358.257.857.557.6
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents103.0102.3135.8135.052.161.045.161.033.640.450.860.964.888.887.942.6
Short Term Investments284.7272.3252.4331.8380.7306.7267.1196.4109.8100.992.368.965.631.661.0155.5
Total Cash & ST Investments387.7374.6388.3466.9432.8367.7312.1257.4143.4141.3143.2129.8130.4120.4148.9198.0
Accounts Receivable41.947.134.233.532.530.026.428.817.620.316.33.72.01.21.60.5
Inventory1.51.71.41.21.01.31.11.00.80.81.35.20.50.10.00.0
Other Current Assets8.215.49.217.712.010.114.512.08.011.85.73.12.73.90.00.0
Total Current Assets439.2438.9432.9519.3478.3409.1354.1299.1169.9174.2166.5141.7135.6126.0153.5202.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents70.081.0111.8102.3100.5103.0125.2135.8183.2150.0
Short Term Investments223.7244.6229.1272.3275.8284.7269.0252.4306.7339.3
Total Cash & ST Investments293.8325.6340.9374.6376.3387.7394.1388.3489.9489.4
Accounts Receivable50.545.044.647.142.841.936.734.229.333.6
Inventory2.02.21.91.71.61.51.51.41.01.1
Other Current Assets21.222.220.515.411.88.27.19.216.49.5
Total Current Assets367.5394.9407.9438.9432.4439.2439.4432.9536.6533.5
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment8.712.79.111.012.414.615.04.45.35.04.62.42.22.31.00.9
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets117.6114.1121.418.620.121.623.024.526.127.838.826.75.06.58.09.5
Long-Term Investments0.50.00.00.00.00.00.00.00.00.00.00.00.00.019.0-1.6
Other Long-Term Assets8.99.110.011.48.16.63.94.04.23.43.20.80.50.61.1-1.2
Total Long-Term Assets212.2217.3215.5115.0115.5124.3129.633.035.636.246.530.07.79.529.110.9
Total Assets651.4656.2648.4634.2593.8533.5483.7332.1205.4210.4213.1171.7143.3135.4182.6213.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment11.912.512.512.78.28.79.09.19.69.9
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets108.8110.6112.3114.1115.8117.6119.4121.417.417.8
Long-Term Investments0.00.00.00.00.00.50.50.50.50.5
Other Long-Term Assets9.89.610.19.19.38.99.09.59.89.5
Total Long-Term Assets233.6229.8224.0217.3212.7212.2213.3215.5105.0108.2
Total Assets601.1624.7631.9656.2645.1651.4652.7648.4641.6641.7
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable3.83.57.112.70.90.00.00.020.316.215.80.80.70.31.00.6
Short-Term Debt2.44.32.42.32.32.12.10.00.00.00.06.70.00.00.00.0
Other Current Liabilities33.492.278.276.471.263.857.453.050.034.135.66.85.45.23.43.6
Current Liabilities93.8100.087.791.474.465.959.553.070.450.351.37.832.932.331.631.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.02.26.03.55.83.86.67.13.52.2
Short-Term Debt0.04.74.44.32.52.42.42.42.42.4
Other Current Liabilities117.9114.693.592.280.887.684.478.279.082.9
Current Liabilities117.9121.5103.9100.089.193.893.387.784.887.4
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt6.08.17.08.810.111.512.50.00.00.00.00.00.00.00.00.0
Capital Leases6.012.47.08.810.113.612.50.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities108.9117.7103.5107.088.980.272.856.774.079.080.010.999.2125.5149.1175.4
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt6.27.07.48.15.56.06.57.07.57.9
Capital Leases6.211.67.412.47.96.06.59.47.57.9
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities135.1138.4120.5117.7103.9108.9108.7103.598.5101.8
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0
Retained Earnings-164.1-174.3-155.4-157.9-164.2-197.3-220.7-336.2-361.4-345.9-327.8-288.0-311.4-291.1-263.4-253.6
Comprehensive Income-0.30.10.0-1.2-0.20.20.20.00.00.10.00.00.00.00.00.0
Total Common Equity542.5538.5544.9527.2504.9453.3410.9275.4131.4131.3133.0160.844.19.933.537.7
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-253.6-231.0-203.8-174.3-169.4-164.1-159.5-155.4-153.0-153.1
Comprehensive Income0.50.40.40.10.7-0.3-0.40.0-1.0-0.9
Total Common Equity466.0486.3511.4538.5541.2542.5544.0544.9543.1539.9
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt8.412.49.411.110.113.612.50.00.00.00.00.00.00.00.00.0
Book Value542.5538.5544.9527.2504.9453.3410.9275.4131.4131.3133.0160.844.19.933.537.7
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value466.0486.3511.4538.5541.2542.5544.0544.9543.1539.9
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-10.9-220.5-18.92.56.333.223.3115.625.2-15.6-18.0-39.920.2-20.3-27.7-9.87.2
Depreciation & Amortization5.9-1.08.13.02.72.82.92.93.03.011.913.62.81.92.12.01.8
Stock-Based Compensation13.09.512.414.016.315.413.413.511.710.58.58.05.94.64.15.55.0
Change Working Capital-1.68.3-6.6-0.76.12.74.33.1-7.80.0-11.129.5-33.0-26.0-25.9-28.8-20.4
Change In Accounts Receivable-8.3-7.5-13.0-0.7-1.1-2.5-3.82.3-11.22.5-4.3-12.7-1.6-0.90.5-1.12.7
Change In Accounts Payable7.415.81.7-11.011.83.07.80.7-4.96.00.69.40.20.4-0.70.3-1.8
Change In Inventories-0.7-3.50.0-0.8-4.5-2.2-2.9-0.70.1-1.10.20.4-2.21.3-0.1-1.72.4
Other Non-cash Items12.812.8-4.4-4.7-0.53.41.7-1.30.20.60.70.7-77.60.21.80.9-2.7
Cash from Operations-5.10.00.012.832.064.251.845.930.0-2.0-8.112.4-81.6-39.6-44.9-28.4-10.9
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-141.2-22.6-27.2-29.5-4.9-5.3-4.5-4.1-2.40.1
Depreciation & Amortization5.92.1-2.82.02.02.02.02.21.20.6
Stock-Based Compensation2.32.12.13.00.03.03.03.63.33.2
Change Working Capital3.0-8.115.3-1.90.7-9.6-4.67.02.8-6.8
Change In Accounts Receivable-4.1-5.6-0.42.5-4.4-0.8-5.2-2.6-4.84.3
Change In Accounts Payable9.1-10.211.35.6-2.10.00.01.23.3-0.3
Change In Inventories-1.30.0-0.4-1.9-0.1-0.20.30.0-0.4-0.6
Other Non-cash Items-2.60.95.31.12.3-1.5-1.5-0.8-1.1-1.9
Cash from Operations0.00.00.00.00.00.00.00.0-3.7-2.1
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.4-1.0-0.5-0.4-0.7-0.6-1.8-1.0-25.4-1.7-1.4-2.5-8.8-0.2-2.0-0.30.0
Acquisitions-140.20.0-4.2-100.70.00.0-0.20.025.00.00.00.0-8.00.00.00.00.0
Investments-290.3-112.4-364.8-512.6-349.3-420.5-346.6-394.5-282.4-148.1-165.4-193.1-93.3-65.6-60.9-160.2-202.4
Sales of Investment353.6208.2352.1601.6399.9344.3306.9327.2198.1139.6156.8169.089.831.5108.6234.846.8
Other Investing Activities88.30.00.00.00.00.00.20.0-25.00.10.00.08.20.00.0-0.60.1
Cash from Investing-41.90.00.0-12.149.9-76.7-41.5-68.3-109.7-10.1-10.1-26.6-12.0-34.345.873.7-155.6
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.1-0.2-0.3-0.4-0.2-0.2-0.10.0-0.30.0
Acquisitions0.00.00.00.00.00.00.0-2.7-100.7-35.4
Investments-2.0-14.0-53.0-43.3-92.4-83.7-112.6-76.0-55.0-46.6
Sales of Investment47.035.638.087.796.696.099.060.5112.182.0
Other Investing Activities0.00.00.00.00.00.00.00.057.135.4
Cash from Investing0.00.00.00.00.00.00.00.0-43.835.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Debt Issued0.512.43.0-1.71.1-3.61.212.50.00.00.00.00.00.00.00.00.0
Issuance of Common Stock0.00.00.00.00.70.00.00.0100.90.00.00.087.348.50.00.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.03.65.66.36.35.37.84.12.41.40.00.03.8
Cash from Financing0.00.00.00.00.73.65.66.3107.15.37.84.189.749.90.00.03.8
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued6.2-5.4-0.1-0.64.4-0.5-0.5-0.51.9-0.5
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.00.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-47.1-17.4-33.50.882.9-9.016.0-16.127.4-6.8-10.4-10.1-3.9-24.00.845.4-162.7
Closing Cash Balance103.085.3102.8136.3135.552.661.645.761.733.640.450.860.964.888.887.942.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash14.9-11.0-30.89.51.8-2.5-22.2-10.7-47.433.2
Closing Cash Balance85.370.581.5112.3102.3101.0103.4125.6136.3183.7
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-5.5-110.4-16.212.431.363.750.044.94.6-3.6-9.59.9-90.3-39.8-46.9-28.7-10.9
Real Free Cash Flow-18.5-119.9-28.7-1.615.048.336.631.5-7.0-14.1-18.12.0-96.2-44.4-51.0-34.2-15.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-29.5-31.8-15.6-33.6-2.0-14.7-7.07.6-4.0-2.1
Real Free Cash Flow-31.8-33.9-17.7-36.6-2.0-17.7-10.04.0-7.3-5.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.926.1-1.4
P/S1.94.99.4
P/B0.920.45.2
P/FCF-3.513.6-1.5
Market cap$0.3$0.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %0.9 %0 %
Debt to Income-2.8 %16.7 %0 %
Debt to Free cash flow-5.2 %20.7 %0 %
Interest expense percentage0 %40.2 %44.7 %
Current ratio3.1 4.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-47.3 %-216.4 %0 %
ROA-36.7 %-3.3 %0 %
CapEx to Revenue0.5 %3 %0 %
RaD to Revenue0 %42.6 %0 %
ROEM587,241.8 708626

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin93.2 %91.5 %68.7 %
Operating margin-71.6 %-14.9 %35.5 %
Net margin-102 %-11.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding59.1 mil 45.7 mil
Employee count0.4 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader